FTC 200mg+TDF 300mg tabs/PAC-30 No CTN

General description:
Emtricitabine 200mg + Tenofovir disoproxil fumarate 300mg tablets, bottle pack of 30 without outer carton

Technical Specifications
Each film coated tablet contains Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil as fixed dose combination (FDC).

Therapeutic class
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Dosage, Instructions for use:
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.